Prostanoids vs pentoxifylline
It is very uncertain whether prostanoids changes rest‐pain relief compared with pentoxifylline (very low certainty).
- RR 1.4 [0.72, 2.72]1 study · 70 participantsVery low
It is very uncertain whether prostanoids changes rest‐pain relief compared with pentoxifylline (very low certainty).
It is very uncertain whether prostanoids changes ulcer healing compared with pentoxifylline (very low certainty).
The review found no eligible studies for this question.
Prostanoids showed no clear difference in total amputations compared with naftidrofuryl (low certainty).
The review found no eligible studies for this question.
Prostanoids showed no clear difference in adverse events (participants) compared with naftidrofuryl (low certainty).
Prostanoids showed no clear difference in rest‐pain relief compared with naftidrofuryl (low certainty).
Prostanoids showed no clear difference in ulcer healing compared with naftidrofuryl (low certainty).
The review found no eligible studies for this question.
Prostanoids showed no clear difference in total amputations compared with placebo (high certainty).
PGE1 may leads to lower total amputations compared with ATP (low certainty).
The review found no eligible studies for this question.
PGE1 may leads to higher adverse event (participants) compared with ATP (low certainty).
PGE1 showed no clear difference in ulcer healing (complete) compared with ATP (low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
PGE1 showed no clear difference in adverse events (participants) compared with inositol niacinate (low certainty).
PGE1 showed no clear difference in rest‐pain relief compared with inositol niacinate (low certainty).